The University of Western Australia
An international research team has found a way to awaken the immune system's ability to kill spreading cancer cells.
The key finding published in Nature is that the spread of
cancer cells can be markedly reduced by targeting the biochemical
activity of TAM receptors.
The finding came from studying natural killer cells, a type of blood cell that can induce the death of cancer cells.
Co-author, Research Professor Wally Langdon from The University of
Western Australia School of Pathology and Laboratory Medicine said it
was found that mice without healthy versions of another protein called
Cbl-b had natural killer cells that had a heightened ability to prevent
the spread of cancer cells.
"It was then discovered that the Cbl-b protein regulates the activity
of TAM receptors, and therefore the anti-cancer effect seen in Cbl-b
mutant mice might be mediated through its effects on TAM receptors,"
Professor Langdon said.
To test this possibility the team developed a new drug, a highly
selective TAM inhibitor that blocked the receptors. It was found that
treating mice with the TAM inhibitor significantly reduced the spread of melanoma and breast cancer cells.
"These findings reveal that a drug such as the TAM inhibitor can
awaken the immune system's ability to kill spreading cancer cells,
therefore providing an additional approach to enhance cancer treatment,"
Professor Langdon said.
Editor's note: Original news release can be found here.
No comments:
Post a Comment